NEW YORK, Feb. 6 (GenomeWeb News) - OGT Services announced today that Oxford Genetics Knowledge Park is using its custom-made microarrays to develop tests for use in NHS Regional Genetics Laboratories.

 

The microarrays will be used to develop tests for complex diseases such as colorectal cancer, cardiovascular diseases, and learning disabilities, said OGT.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Consulting company McKinsey says diagnostics companies will have to combine genomic data analysis, electronic medical records, effective reimbursement strategies, and regulatory compliance in order to win.

A new report has found that researchers in Africa are still heavily dependent on funding from organizations in the US, Europe, and China, Nature News says.

An article in The Atlantic argues that the progress being made in science isn't keeping pace with the money and time being spent on research.

In Science this week: a CRISPR screen identifies sideroflexin 1 as a requisite component of one-carbon metabolism, and more.